NeuroPrecision is developing a wearable sensor system to objectively track progress in autism therapies. Autism affects over 3.5 million individuals in the US and costs $269 billion annually. Existing therapy tracking relies on subjective measurements. NeuroPrecision's sensors can profile autistic and typically developing children to objectively measure 18 parameters. This solution will benefit parents, payers, and therapists by providing objective therapy evaluations, tracking progress over time, and improving reimbursements. NeuroPrecision aims to reach occupational therapists initially and estimates a $1.5 billion market size for autism therapy tracking.